Rein Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Rein Therapeutics, Inc. (RNTX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $116.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $116.00K.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $318.00K.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $157.00K.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $152.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value |
|---|---|
| 2026-06-30 | $116.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $318.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $157.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $152.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $447.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $910.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.60M 10-K · filed 2026-03-26 |
| 2024-09-30 | $3.37M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.30M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $8.86M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.90M 10-K · filed 2025-04-07 |
| 2022-03-31 | $25.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.00K 10-K · filed 2023-03-20 |
| 2021-09-30 | $437.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $808.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $1.26M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $606.00K 10-K · filed 2022-03-28 |
| 2019-03-31 | $18.00K 10-Q · filed 2019-05-08 |
| 2018-09-30 | $241.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $875.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $4.13M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $7.20M 10-K · filed 2019-03-29 |
| 2017-09-30 | $11.24M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $8.06M 10-Q · filed 2017-08-10 |
| 2016-12-31 | $1.29M 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |